Lydia A.
- Country
- Spain
- Department
- Rheumatology
Research Overview
- Evaluation of Cenerimod Efficacy and Safety in Adults with Moderate-to-Severe Systemic Lupus Erythematosus: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Long-Term Safety and Tolerability of Cenerimod in Adults with Moderate-to-Severe Systemic Lupus Erythematosus on Background Therapy
Data & Insights
Has run more than one trial at 19 of 54 partner sites.
Specializations
Breast Cancer and Solid Tumors
Lydia Abasolo is involved in clinical research focused on breast cancer, especially hormone receptor-positive, HER2-negative, triple-negative, and metastatic breast cancer, together with broader studies in advanced solid tumors and other difficult-to-treat malignancies.
- Advanced breast cancer
- Triple-negative breast cancer
- Metastatic solid tumors
- Endocrine-resistant disease
Her therapeutic interests also extend to HER2-positive and HER2-low disease, with attention to treatment options for recurrent, locally advanced, and metastatic settings.
Genitourinary Oncology
Her research landscape includes a strong focus on renal cell carcinoma, urothelial carcinoma, and bladder cancer, covering both localized and advanced disease.
- Renal cell carcinoma
- Urothelial carcinoma
- Muscle-invasive bladder cancer
- Metastatic genitourinary cancer
She is also involved in studies addressing prostate cancer, including castration-resistant and metastatic forms, reflecting interest across major genitourinary malignancies.
Thoracic, Head and Neck, and Gastrointestinal Cancers
Her clinical trial activity spans non-small cell lung cancer, small cell lung cancer, head and neck squamous cell carcinoma, and several gastrointestinal cancers, including colorectal cancer, gastric cancer, and hepatocellular carcinoma.
- Non-small cell lung cancer
- Head and neck squamous cell carcinoma
- Colorectal cancer
- Hepatocellular carcinoma
Her involvement also covers gastroesophageal junction and pancreatic malignancies, supporting research in advanced cancer care across multiple tumor types.
Autoimmune, Renal, and Inflammatory Diseases
Lydia Abasolo’s non-oncology research includes rheumatologic, renal, and immune-mediated conditions such as systemic lupus erythematosus, lupus nephritis, IgA nephropathy, and focal segmental glomerulosclerosis.
- Systemic lupus erythematosus
- Lupus nephritis
- IgA nephropathy
- Focal segmental glomerulosclerosis
Her therapeutic interests also include psoriasis, chronic spontaneous urticaria, thyroid eye disease, and other autoimmune disorders affecting skin, kidney, and systemic inflammation.
Cardiovascular, Neurological, and Metabolic Disorders
Her portfolio further includes cardiovascular disease, heart failure, atrial fibrillation, hypertension, and atherosclerotic disease, alongside neurological and metabolic conditions.
- Acute and chronic cardiovascular disease
- Multiple sclerosis
- Epilepsy
- Obesity
She is also involved in research on Alzheimer’s disease, migraine, and diabetic retinopathy, showing interest in chronic diseases with significant neurological, vascular, and metabolic impact.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.